GRM3 and Anxiety: One possible explanation for these null results is compensatory changes in gene expression and/or redundancy of function between these two homologous receptor subtypes for the anxiety phenotype in the single KO lines (Lyon et al., 2008), whereas pharmacological ligands will activate or inhibit both mGlu2 and mGlu3.